Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.
- Chamber
- Senate
- Introduced
- Jan 17, 2025
- Last action
- Jan 17, 2025 — Introduced.
- Session
- 2026
- Momentum
- 31 · Low